샘플 요청 목록

 카트 문의
시장보고서
상품코드
1757939

세계의 중독 치료학 시장

Addiction Therapeutics
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 281 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 중독 치료학 시장은 2030년까지 360억 달러에 달할 전망

2024년에 252억 달러로 추정되는 세계의 중독 치료학 시장은 2024-2030년에 CAGR 6.2%로 성장하며, 2030년에는 360억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 알코올 중독 치료학은 CAGR 4.9%를 기록하며, 분석 기간 종료시에는 182억 달러에 달할 것으로 예측됩니다. 담배 중독 치료학 부문의 성장률은 분석 기간 중 CAGR 7.8%로 추정됩니다.

미국 시장은 69억 달러, 중국은 CAGR 9.5%로 성장 예측

미국의 중독 치료학 시장은 2024년에 69억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 73억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 9.5%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.1%와 6.0%로 예측됩니다. 유럽에서는 독일이 CAGR 4.0%로 성장할 것으로 예측됩니다.

세계의 중독 치료학 시장 - 주요 동향과 촉진요인 정리

중독 치료학이 공중보건, 행동의학, 의약품 혁신에서 전략적 중요성이 커지고 있는 이유는 무엇인가?

오피오이드 중독, 알코올 중독, 니코틴 중독, 각성제 중독과 같은 약물 사용 장애(SUDs)의 부담이 계속 증가함에 따라 중독 치료는 전 세계 보건의 시급한 과제가 되고 있습니다. 중독이 도덕적 실패가 아닌 만성적인 신경행동학적 상태라는 인식이 널리 퍼지면서 약리학적 개입이 종합적인 치료 전략의 핵심으로 받아들여지고 있습니다. 갈망, 금단 증상 및 재발 방지를 목표로 하는 약물 치료는 재활, 정신과 및 1차 진료의 모든 영역에서 임상적 지지를 받고 있습니다.

북미의 오피오이드 위기, 유럽의 알코올 중독, 아시아태평양의 각성제 남용 증가로 인해 각국 정부는 중독 치료를 국가적 보건의료 과제로 우선순위를 정하고 있습니다. 정신건강 문제 증가, 경제적 불안, 팬데믹으로 인한 고립 등 보다 광범위한 사회적 요인으로 인해 접근이 용이하고 증거에 기반한 치료 솔루션에 대한 필요성이 더욱 커지고 있습니다. 수요가 증가함에 따라 중독 치료학은 공공 보험 제도, 직원 지원 프로그램, 법원에서 강제하는 치료 구상에 통합되고 있습니다.

중독 치료의 약물 혁신은 신경 수용체(오피오이드, 도파민, GABA 등)를 조절하고, 보상 경로를 차단하며, 우울증과 불안증을 포함한 이중 진단을 관리하는 약물 개발에 집중하고 있습니다. 이러한 치료법은 물질 의존성을 감소시킬 뿐만 아니라 신경학적 균형과 행동 기능을 회복하도록 설계되어 회복 지향적 의료 모델에서 중심적인 역할을 강조하고 있습니다.

새로운 메커니즘, 디지털 통합, 정책 개혁은 중독 치료학을 어떻게 진화시키고 있는가?

신경약리학의 발전으로 중독 치료제 파이프라인이 확장되고 있으며, 보다 표적화되고 내약성이 높은 중재를 제공합니다. 장기 지속형 주사제, 디포제제, 이식형 디바이스는 순응도 문제를 해결하고 오남용의 가능성을 줄여줍니다. 보상 회로 부분 작용제, 길항제, 조절제는 알코올과 오피오이드에서 도박과 게임과 같은 새로운 행동 중독에 이르기까지 다양한 중독에 대한 임상 개발이 진행 중입니다.

모바일 건강 앱, 가상 행동 지원, AI를 통한 순응도 모니터링과 같은 디지털 툴의 통합은 약물 치료의 효과를 높이고 있습니다. 이러한 툴은 약물 복용 알림, 갈망 추적, 가상 치료 지원을 용이하게 하고, 약리학적 치료와 심리사회적 치료를 통합한 하이브리드 치료 모델을 제공합니다. 디지털 치료(DTx)는 특히 원격의료가 도입된 시장과 가치 기반 치료 모델에 대한 지불자의 지원이 있는 시장에서 처방약과 결합하는 사례가 증가하고 있습니다.

정책 개혁으로 중독 치료제에 대한 오랜 접근 장벽이 제거되고 있습니다. 간호사에게 처방권 확대, 특정 약물에 대한 상담 의무화 축소, 병용요법에 대한 상환 합리화 등이 중독 치료제의 접근을 촉진하고 있습니다. 또한 규제 당국은 중독 위기의 긴급성을 인식하고 획기적인 치료제의 신속한 승인을 위해 패스트 트랙 제도와 우선 심사 제도를 도입하고 있습니다. 이러한 개혁은 조기 개입을 촉진하고, 낙인을 줄이고, 징벌적 접근보다 피해 감소를 우선시함으로써 치료 환경을 재구성하고 있습니다.

중독 치료학의 성장을 주도하는 환자군, 치료 수단, 지역 시장은?

주요 환자군에는 오피오이드 사용 장애(OUD) 환자가 포함되며, 특히 미국과 캐나다에서 현재 치료제의 주요 초점이 되고 있습니다. 알코올 사용 장애(AUD)는 특히 유럽과 라틴아메리카 일부 지역에서 전 세계 치료 수요의 상당 부분을 차지합니다. 처방약과 일반의약품을 포함한 금연치료제는 모든 지역에서 광범위하고 광범위한 접근성을 가진 분야이기도 합니다.

치료 방법은 해독 지원 및 유지 요법부터 재발 예방 및 이중 진단 관리까지 다양합니다. 일반적인 약리학적 약물에는 메타돈, 부프레노르핀, 나트렉손, 아캄프로세이트, 디설피람, 바레니클린 등이 있으며, 각각 특정 물질 의존성 및 환자 프로파일에 따라 다릅니다. 새로운 치료법으로는 카나비노이드 기반 치료법, 환각 보조 중재, 새로운 신경학적 표적을 가진 항갈망제 등이 있습니다.

북미가 중독치료제 시장을 주도하고 있는 이유는 풍부한 헬스케어 자금, 진행 중인 공중보건 위기, 첨단화된 임상 인프라를 기반으로 하고 있습니다. 유럽은 보편적 의료보험제도와 첨단인 약물 정책 환경에 힘입어 근소한 차이로 그 뒤를 잇고 있습니다. 아시아태평양에서는 특히 알코올과 각성제 남용에 시달리는 도시 지역에서 도입이 진행되고 있습니다. 그러나 낙인, 전문 의료 기관에 대한 접근성 제한, 보험 적용 범위의 제한 등이 신흥 시장에서는 여전히 장벽으로 작용하고 있습니다.

중독치료학은 미래의 의료 시스템, 사회 회복력, 정신신경의학 혁신의 형성에 있으며, 어떤 전략적 역할을 할 수 있는가?

중독 치료학은 통합적이고 결과 중심적이며 사회적으로 반응하는 치료 모델로 의료 시스템을 전환하는 데 있으며, 전략적 역할을 할 준비가 되어 있습니다. 중독, 정신건강, 사회적 결정 요인의 연관성이 밝혀짐에 따라 약리학적인 개입은 주거, 고용, 동료 지원, 사법 개혁에 걸친 광범위한 회복 생태계에 통합되고 있습니다.

제약회사와 생명공학 기업은 이러한 모멘텀을 활용하여 외상 후 스트레스 장애, 오피오이드 비복용 만성통증, 신경 재생 등 인접한 치료 영역을 탐구하며 기존 중독 치료를 넘어 혁신의 지평을 넓혀가고 있습니다. 공중보건기관, 보험사, 기술 기반 치료 프로바이더가 참여하는 공동 자금 지원 모델은 데이터가 풍부하고 환자 중심의 맞춤 치료 접근법을 가능하게 합니다.

사회적 태도가 범죄화에서 배려와 과학에 기반한 치료로 변화하는 가운데, 중독 치료학은 세계 산업 분석가들이 약물 관련 장애와 행동 건강 장애를 치료하고 인식하고 궁극적으로 예방하는 방법에 대한 세계 변화의 초석이 될 수 있는가?

부문

유형(알코올 중독 치료학, 담배 중독 치료학, 약물 중독 치료학); 유통 채널(병원 약국, 소매 약국, 기타 유통 채널)

조사 대상 기업의 예(합계 44 주목)

  • Alkermes plc
  • Alkaloid AD Skopje
  • Biovail Corporation
  • Camurus AB
  • Durect Corporation
  • Indivior PLC
  • Jazz Pharmaceuticals plc
  • Lundbeck A/S
  • Mallinckrodt Pharmaceuticals
  • MediciNova, Inc.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Retrophin, Inc.
  • Shionogi & Co., Ltd.
  • Sunovion Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Titan Pharmaceuticals, Inc.
  • Zogenix, Inc.

AI 통합

우리는 유효한 전문가 컨텐츠와 AI 툴로 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA

Global Addiction Therapeutics Market to Reach US$36.0 Billion by 2030

The global market for Addiction Therapeutics estimated at US$25.2 Billion in the year 2024, is expected to reach US$36.0 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Alcohol Addiction Therapeutics, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$18.2 Billion by the end of the analysis period. Growth in the Tobacco Addiction Therapeutics segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 9.5% CAGR

The Addiction Therapeutics market in the U.S. is estimated at US$6.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.3 Billion by the year 2030 trailing a CAGR of 9.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Addiction Therapeutics Market - Key Trends & Drivers Summarized

Why Are Addiction Therapeutics Gaining Strategic Significance Across Public Health, Behavioral Medicine, and Pharmaceutical Innovation?

Addiction therapeutics are becoming a global health imperative as the burden of substance use disorders (SUDs)-including opioid, alcohol, nicotine, and stimulant dependencies-continues to rise. With addiction now widely recognized as a chronic neurobehavioral condition rather than a moral failing, there is growing acceptance of pharmacological intervention as a core component of comprehensive treatment strategies. Therapeutics aimed at managing cravings, withdrawal symptoms, and relapse prevention are gaining clinical traction across rehabilitation, psychiatric, and primary care settings.

The opioid crisis in North America, alcohol dependence in Europe, and increasing stimulant abuse in Asia-Pacific have prompted governments to prioritize addiction treatment under national healthcare agendas. Broader social drivers-such as rising mental health challenges, economic insecurity, and pandemic-induced isolation-are further amplifying the urgency of accessible, evidence-based treatment solutions. As demand escalates, addiction therapeutics are being integrated into public insurance schemes, employee assistance programs, and court-mandated treatment initiatives.

Pharmaceutical innovation in addiction therapy is also gaining momentum, with efforts focused on developing drugs that modulate neuroreceptors (e.g., opioid, dopamine, GABA), block reward pathways, and manage dual diagnoses involving depression or anxiety. These treatments are being designed not only to reduce substance dependence but also to restore neurological balance and behavioral function, highlighting their centrality in recovery-oriented healthcare models.

How Are Novel Mechanisms, Digital Integration, and Policy Reforms Driving the Evolution of Addiction Therapeutics?

The addiction therapeutics pipeline is expanding through advances in neuropharmacology, offering more targeted and tolerable interventions. Long-acting injectables, depot formulations, and implantable devices are addressing adherence challenges and reducing misuse potential. Partial agonists, antagonists, and modulators of reward circuitry are under clinical development for a wide spectrum of addictions-ranging from alcohol and opioids to emerging behavioral addictions like gambling and gaming.

Integration of digital tools-including mobile health apps, virtual behavioral support, and AI-driven adherence monitoring-is enhancing the effectiveness of pharmacotherapy. These tools facilitate medication reminders, craving tracking, and virtual therapy support, offering a hybrid care model that blends pharmacological and psychosocial treatment. Digital therapeutics (DTx) are increasingly paired with prescription drugs, particularly in markets with strong telehealth adoption and payer support for value-based care models.

Policy reforms are removing longstanding access barriers to addiction medications. Expansion of prescribing rights to nurse practitioners, reduction of mandatory counseling requirements for certain medications, and streamlining of reimbursement for combination therapies are catalyzing uptake. Additionally, regulatory bodies are accelerating approvals for breakthrough therapies under fast-track or priority review programs, recognizing the urgency of the addiction crisis. These reforms are reshaping the treatment landscape by promoting early intervention, reducing stigma, and prioritizing harm reduction over punitive approaches.

Which Patient Populations, Treatment Modalities, and Regional Markets Are Driving the Growth of Addiction Therapeutics?

Key patient groups include individuals with opioid use disorder (OUD), which remains the primary focus of current therapeutics, particularly in the U.S. and Canada. Alcohol use disorder (AUD) accounts for a substantial share of treatment demand globally, especially in Europe and parts of Latin America. Tobacco cessation products, including both prescription medications and over-the-counter options, also represent a high-volume, broad-access segment across all geographies.

Treatment modalities range from detoxification support and maintenance therapy to relapse prevention and dual-diagnosis management. Common pharmacological agents include methadone, buprenorphine, naltrexone, acamprosate, disulfiram, and varenicline, each aligned with specific substance dependencies and patient profiles. Emerging modalities include cannabinoid-based therapies, psychedelic-assisted interventions, and anti-craving agents with novel neurological targets.

North America leads the addiction therapeutics market due to robust healthcare funding, ongoing public health crises, and advanced clinical infrastructure. Europe follows closely, supported by universal healthcare systems and progressive drug policy environments. Asia-Pacific is showing increasing adoption, particularly in urban centers grappling with alcohol and stimulant abuse. However, stigma, limited access to specialized providers, and variable insurance coverage remain barriers in emerging markets.

What Strategic Role Will Addiction Therapeutics Play in Shaping Future Health Systems, Societal Resilience, and Neuropsychiatric Care Innovation?

Addiction therapeutics are poised to play a strategic role in transitioning healthcare systems toward integrated, outcomes-focused, and socially responsive models of care. As the link between addiction, mental health, and social determinants becomes more evident, pharmacological interventions are being embedded into broader ecosystems of recovery-spanning housing, employment, peer support, and justice reform.

Pharmaceutical and biotech players are leveraging this momentum to explore adjacent therapeutic areas such as post-traumatic stress disorder, chronic pain without opioids, and neuroregeneration-expanding the innovation horizon beyond conventional addiction treatment. Collaborative funding models involving public health agencies, insurers, and tech-enabled care providers are enabling a data-rich, patient-centered approach to treatment personalization.

With societal attitudes shifting from criminalization to compassion and science-driven care, could addiction therapeutics become the cornerstone of a global transformation in how we treat, perceive, and ultimately prevent substance-related and behavioral health disorders?

SCOPE OF STUDY:

The report analyzes the Addiction Therapeutics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics, Drug Addiction Therapeutics); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Alkermes plc
  • Alkaloid AD Skopje
  • Biovail Corporation
  • Camurus AB
  • Durect Corporation
  • Indivior PLC
  • Jazz Pharmaceuticals plc
  • Lundbeck A/S
  • Mallinckrodt Pharmaceuticals
  • MediciNova, Inc.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Retrophin, Inc.
  • Shionogi & Co., Ltd.
  • Sunovion Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Titan Pharmaceuticals, Inc.
  • Zogenix, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Addiction Therapeutics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Substance Abuse and Mental Health Disorders Throws the Spotlight on Addiction Therapeutics
    • Growth in Public Health and Rehabilitation Spending Spurs Demand for Effective Treatment Options
    • Development of Opioid, Nicotine, and Alcohol Dependence Therapies Expands Drug Pipeline Activity
    • Integration With Behavioral Therapy Enhances Holistic Addiction Management Outcomes
    • Growth in Telemedicine and Digital Monitoring Tools Supports Continuity of Care
    • Use in Correctional Health Programs and Workplace Wellness Initiatives Broadens Treatment Access
    • Expansion of Harm Reduction Programs Promotes Preventive and Early Intervention Approaches
    • Government Incentives and Orphan Drug Designations Support Commercial Viability of Niche Treatments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Addiction Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Alcohol Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Alcohol Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Alcohol Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Tobacco Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Tobacco Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Tobacco Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Drug Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • JAPAN
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CHINA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • EUROPE
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Addiction Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • FRANCE
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • GERMANY
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Addiction Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • INDIA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Addiction Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Addiction Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AFRICA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제